semaglutide and perimenopause What Is Perimenopause? Menopause Weight Gain: Can GLP-1

Archived from the original (PDF) on September 25, 2007

Other reported effects included: Transient fatigue Reduced appetite (therapeutically desirable in the context of weight loss) Mild injection-site reactions Altered skin sensations or cutaneous hyperesthesia (reported in ~7% of participants, mild and non-serious) Serious adverse events were rare and occurred at similar rates in the retatrutide and placebo groups (approximately 4%)

doi: 10.1001/jamainternmed.2023.7268

We have nano-glp1s and bhrt now

That means some things may not work as well, or may start building up in ways you dont expect

Activating these receptors pharmacologically during development could theoretically interfere with normal growth and organ maturation processes